tirzepatide and bimagrumab Phase 2 Study of in Individuals with Obesity Type 2 Antibody blockade of activin type
Description
The most commonly reported adverse events were gastrointestinal in nature including nausea, vomiting, diarrhoea, and constipation a profile consistent with other incretin-based therapies
Continuous variables are presented as meanstandard deviation
What did he actually take
You can pause treatment at any time if you are planning pregnancy or become pregnant
Before starting tirzepatide Baseline labs: Total testosterone, free testosterone, estradiol, SHBG, LH, FSH, complete metabolic panel, lipid panel, HbA1c, vitamin D, zinc, B12
It zigzags, plateaus, and sometimes temporarily reverses due to water retention, hormonal fluctuations, or measurement variation
